Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Theerut Luangmonkong"'
Autor:
Theerut Luangmonkong, Chanitkarn Pransin, Ladawan Nopphalee, Sirada Meechai, Suprawee Chunya, Atis Rattanavaraha, Naphat Kaewnoppharat, Thayida Khuituan, Sanpetch Bunyakiat, Warisara Parichatikanond
Publikováno v:
Pharmaceutical Sciences Asia, Vol 49, Iss 6, Pp 534-542 (2022)
Evaluating effects of putative chemical or herbal agents against a single intraperitoneal administration of carbon tetrachloride (CCl4) in rodents is a widely used model for studying hepatoprotective potency. Since the toxic effects of CCl4 is depend
Externí odkaz:
https://doaj.org/article/2a87eaaa2d2843838dea95e18d8a4a34
Autor:
Theerut Luangmonkong, Jiratchaya Wongsaardsakul, Rujipas Laobutree, Sarawut Jindarat, Nattapon Jaisupa
Publikováno v:
Pharmaceutical Sciences Asia, Vol 49, Iss 2, Pp 121-128 (2022)
Individual conditions are essential in pharmacotherapy of hypertension; however, information regarding the association between anti-hypertensive drugs and co-morbid diseases as recommended in clinical practice guidelines is not well acquainted. There
Externí odkaz:
https://doaj.org/article/205a6dd9201d4be980f186277f8c7b15
Autor:
Pei Pei Chong, Ali Farhadi, Doungdaw Chantasart, Siau Hui Mah, Renukha Sellappans, Eng Hwa Wong, Abbas Behzad Behbahani, Arash Safari, Tahereh Kalantari, Jiraphong Suksiriworapong, Theerut Luangmonkong, Orasa Suriyaphan
Publikováno v:
Life Sciences, Medicine and Biomedicine, Vol 6, Iss 1 (2022)
Graduate Research Symposium 2021 (GRS2021) was held virtually via Zoom on the 30th of November 2021. The theme of the symposium was Scientific Research Today: Borderless, Collaborative and Innovative. The symposium aimed to highlight the various type
Externí odkaz:
https://doaj.org/article/c2756dc91c0a4c37857707fcfefb43d6
Autor:
Theerut Luangmonkong, Pittaya Puphancharoensuk, Varisara Tongsongsang, Peter Olinga, Warisara Parichatikanond
Publikováno v:
Biomedicines, Vol 11, Iss 1, p 231 (2023)
The continuous death of hepatocytes induced by various etiologies leads to an aberrant tissue healing process and promotes the progression of liver fibrosis and ultimately chronic liver diseases. To date, effective treatments to delay this harmful pr
Externí odkaz:
https://doaj.org/article/810ac61461064de087ef026f32cd6798
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Transforming growth factor-β (TGF-β) is a common mediator of cancer progression and fibrosis. Fibrosis can be a significant pathology in multiple organs, including the heart. In this review, we explain how inhibitors of TGF-β signaling can work as
Externí odkaz:
https://doaj.org/article/8ad3c74f01c14805a5eccc62e53af91d
Autor:
Adhyatmika Adhyatmika, Leonie Beljaars, Kurnia S. S. Putri, Habibie Habibie, Carian E. Boorsma, Catharina Reker-Smit, Theerut Luangmonkong, Burak Guney, Axel Haak, Keri A. Mangnus, Eduard Post, Klaas Poelstra, Kim Ravnskjaer, Peter Olinga, Barbro N. Melgert
Publikováno v:
Pharmaceutics, Vol 12, Iss 5, p 471 (2020)
Osteoprotegerin (OPG) serum levels are associated with liver fibrogenesis and have been proposed as a biomarker for diagnosis. However, the source and role of OPG in liver fibrosis are unknown, as is the question of whether OPG expression responds to
Externí odkaz:
https://doaj.org/article/b319b910af32449c8e3333c092aedcec
Autor:
Su Suriguga, Mei Li, Theerut Luangmonkong, Miriam Boersema, Koert P. de Jong, Dorenda Oosterhuis, A. R. Gorter, Leonie Beljaars, Peter Olinga
Publikováno v:
American journal of physiology. Gastrointestinal and liver physiology, 323(2), G114-G125. AMER PHYSIOLOGICAL SOC
Patients with acute-on-chronic liver failure (ACLF) are at risk of developing acute hepatic decompensation and organ failures with an unraveled complex mechanism. An altered immune response toward insults in cirrhotic compared with healthy livers may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ce876ddd2a2b15cdb0a8bf0979af82
https://research.rug.nl/en/publications/29c698a9-8e72-4d01-9ae1-87fc6d931527
https://research.rug.nl/en/publications/29c698a9-8e72-4d01-9ae1-87fc6d931527
Autor:
Theerut Luangmonkong, Peter Olinga
Publikováno v:
Pharmaceutical Sciences Asia, 47(3), 301-309
Precision-cut liver slices (PCLS) have been widely utilized in various multicellular studies due to liver architecture and intercellular communication remain preserved. In studying anti-fibrotic drugs using PCLS, the culture method is currently based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c103a94a6140cdac3107a8027178d9e6
https://hdl.handle.net/11370/27f5333f-f5e0-4a0c-953a-c79e55dd2268
https://hdl.handle.net/11370/27f5333f-f5e0-4a0c-953a-c79e55dd2268
Autor:
Bao Tung Pham, Dorenda Oosterhuis, Peter Olinga, S. Suriguga, Raditya Iswandana, Henricus A. M. Mutsaers, Louise A van Wijk, Yvette J. M. Jansen, Theerut Luangmonkong
Publikováno v:
Inflammatory Bowel Diseases, 26(5), 678-686. LIPPINCOTT WILLIAMS & WILKINS
Iswandana, R, Pham, B T, Suriguga, S, Luangmonkong, T, van Wijk, L A, Jansen, Y J M, Oosterhuis, D, Maria Mutsaers, H A & Olinga, P 2020, ' Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs ', Inflammatory Bowel Diseases, vol. 26, no. 5, pp. 678-686 . https://doi.org/10.1093/ibd/izz329
Inflammatory Bowel Diseases
Iswandana, R, Pham, B T, Suriguga, S, Luangmonkong, T, van Wijk, L A, Jansen, Y J M, Oosterhuis, D, Maria Mutsaers, H A & Olinga, P 2020, ' Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs ', Inflammatory Bowel Diseases, vol. 26, no. 5, pp. 678-686 . https://doi.org/10.1093/ibd/izz329
Inflammatory Bowel Diseases
Background Intestinal fibrosis is a hallmark of Crohn’s disease. Here, we investigated the impact of several putative antifibrotic compounds on the expression of fibrosis markers using murine precision-cut intestinal slices. Methods Murine precisio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f07eb3c31b014f633eab024331fa8a
https://research.rug.nl/en/publications/f096b1a0-e9f4-47cd-b1c2-69313179b8e0
https://research.rug.nl/en/publications/f096b1a0-e9f4-47cd-b1c2-69313179b8e0
Autor:
Peter Olinga, Detlef Schuppan, Koert P. de Jong, Miriam Boersema, Henricus A. M. Mutsaers, Dorenda Oosterhuis, Theerut Luangmonkong, Emilia Bigaeva, S. Suriguga
Publikováno v:
British Journal of Pharmacology. 174:3107-3117
Background and Purpose Liver fibrosis is a major cause of liver-related mortality and, so far, no effective antifibrotic drug is available. Galunisertib, a TGF-β receptor type I kinase inhibitor, is a potential candidate for the treatment of liver f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::638767dad6ee8622116cd6c8716b3c92
https://doi.org/10.1111/bph.13945
https://doi.org/10.1111/bph.13945